David Spellman

David Spellman

No más puestos en curso

Fortuna: 705 443 $ al 29/02/2024

48 años
Health Technology
Consumer Services

Perfil

David A.
Spellman
is former Chief Financial Officer at Mersana Therapeutics, Inc., former Chief Financial & Business Officer at Intarcia Therapeutics, Inc., former Treasurer, Chief Financial & Accounting Officer of Akebia Therapeutics, Inc. and former VP-Commercial & International Finance at Vertex Pharmaceuticals, Inc. He received an undergraduate degree from The Wharton School of the University of Pennsylvania.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
16/05/2023 446 483 ( 0.24% ) 705 443 $ 29/02/2024

Antiguos cargos conocidos de David Spellman.

EmpresasCargoFin
AKEBIA THERAPEUTICS, INC. Director of Finance/CFO 23/06/2023
Director of Finance/CFO 29/06/2020
MERSANA THERAPEUTICS, INC. Director of Finance/CFO 30/06/2019
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal -
Ver el detalle de la experiencia de David Spellman.

Formación de David Spellman.

The Wharton School of the University of Pennsylvania Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de David Spellman.

Relaciones

24

Relaciones de 1er grado

5

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

MERSANA THERAPEUTICS, INC.

Health Technology

AKEBIA THERAPEUTICS, INC.

Health Technology

Empresas privadas1

Health Technology

Ver las conexiones de la empresa
  1. Bolsa
  2. Insiders
  3. David Spellman